GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Additional Paid-In Capital

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Additional Paid-In Capital : €13.70 Mil(As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Additional Paid-In Capital?


Oxford Cannabinoid Technologies Holdings's quarterly additional paid-in capital declined from Oct. 2022 (€13.67 Mil) to Apr. 2023 (€13.49 Mil) but then increased from Apr. 2023 (€13.49 Mil) to Oct. 2023 (€13.70 Mil).

Oxford Cannabinoid Technologies Holdings's annual additional paid-in capital increased from May. 2020 (€0.00 Mil) to May. 2021 (€13.77 Mil) but then declined from May. 2021 (€13.77 Mil) to Apr. 2023 (€13.49 Mil).


Oxford Cannabinoid Technologies Holdings Additional Paid-In Capital Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Additional Paid-In Capital Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Additional Paid-In Capital
0.86 6.36 - 13.77 13.49

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only 13.77 14.00 13.67 13.49 13.70

Oxford Cannabinoid Technologies Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Oxford Cannabinoid Technologies Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines